Open access
2,921
Views
3
CrossRef citations to date
0
Altmetric
Report
In vitro affinity optimization of an anti-BDNF monoclonal antibody translates to improved potency in targeting chronic pain states in vivo
Edwina Stacka Biomedicine Design, Pfizer, Dublin, Ireland
, Sheridan McMurrayb Neusentis, Pfizer, Cambridge, UK
, Gordon McMurrayb Neusentis, Pfizer, Cambridge, UK
, Jason Wadea Biomedicine Design, Pfizer, Dublin, Ireland;c Biomedicine Design, Pfizer, Cambridge, US
, Melissa Clarkb Neusentis, Pfizer, Cambridge, UK
, Gareth Youngb Neusentis, Pfizer, Cambridge, UK
, Kim Marquettec Biomedicine Design, Pfizer, Cambridge, US
, Sadhana Jainc Biomedicine Design, Pfizer, Cambridge, US
, Kerry Kelleherc Biomedicine Design, Pfizer, Cambridge, US
, Ting Chenc Biomedicine Design, Pfizer, Cambridge, US
, Qingcong Linc Biomedicine Design, Pfizer, Cambridge, US
, Laird Bloomc Biomedicine Design, Pfizer, Cambridge, US
, Laura Linc Biomedicine Design, Pfizer, Cambridge, US
, William Finlaya Biomedicine Design, Pfizer, Dublin, Ireland
, Rie Suzukib Neusentis, Pfizer, Cambridge, UKCorrespondence[email protected]
& Orla Cunninghama Biomedicine Design, Pfizer, Dublin, IrelandCorrespondence[email protected]
https://orcid.org/0000-0002-3888-9541
Article: 1755000
|
Received 02 Dec 2019, Accepted 06 Apr 2020, Published online: 24 Apr 2020
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.